EQT’s Sagility B.V. to sell $315Mn stake in Sagility India via OFS
AMSTERDAM, NETHERLANDS — Sagility B.V., the Netherlands-based promoter of India-listed Sagility Ltd., is set to sell up to 15.02% of its stake in the healthcare-focused outsourcing firm through an offer for sale (OFS) worth as much as ₹2,671 crore ($314.7 million).
The base offer includes 346.13 million shares, or 7.39% of Sagility India’s equity. If oversubscribed, the offer may be expanded to 703 million shares, representing a 15.02% stake.
The floor price is set at ₹38 per share—an 11.4% discount to the May 26 closing price of ₹42.87 on the National Stock Exchange.
No fresh issue; promoter stake falls
This is a pure secondary transaction, with no new shares issued. Sagility B.V., owned by private equity giant EQT, currently holds 82.39% of Sagility India. A full sale under this OFS would reduce the company’s holding and help it move closer to meeting the minimum public shareholding norms.
The promoter had already offloaded a 702.2 million-share stake during Sagility India’s ₹2,106 crore ($248 million) IPO in November 2024. That offer was also entirely an OFS and was oversubscribed more than three times.
Healthcare BPO with global reach
Sagility India provides technology-enabled business process management (BPM) services, primarily for the U.S. healthcare sector.
With over 30,000 employees across the U.S., India, Jamaica, the Philippines, and Colombia, the company supports payers, providers, and healthcare tech firms in driving efficiency and compliance.
Sagility reported earnings for the March 2025 quarter, with consolidated net profit surging 127.6% year-on-year to ₹182.57 crore ($21.5 million). Revenue climbed 22.2% to ₹1,568.48 crore ($185 million), reinforcing its position in a recession-resilient segment marked by steady demand and non-discretionary spending.
Related news
- Hospitals in U.S. harness AI to boost operating room efficiency · 3 Jun
- U.S. senior care providers harness AI to streamline operations · 5 Jun
- Sagility India IPO raises $112Mn from global investors · 5 Nov 2024
Disclosure: Outsource Accelerator uses AI tools in the backend of its editorial workflow. Every article is reviewed and verified by a human editor before publication.
Stay ahead in healthcare outsourcing. Join thousands of healthcare and business leaders who rely on Outsource Accelerator for the news, trends, and expert insights shaping medical BPO and the future of care delivery. Subscribe to our free newsletter and never miss an update.
